Insulet | PODD - Market Capitalization


Insulet reported $10.7B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Align Technology USD 12.28B 1.07B Mar/2026
AtriCure USD 1.44B 522M Mar/2026
Avanos Medical USD 652M 131M Mar/2026
Baxter International USD 8.67B 1.15B Mar/2026
Becton, Dickinson and Co. USD 44.77B 10.52B Mar/2026
Boston Scientific USD 93.26B 48.09B Mar/2026
Cardinal Health USD 49.72B 894M Mar/2026
Cooper Companies USD 12.38B 105M Jun/2026
Dexcom USD 24.17B 1.72B Mar/2026
Edwards Lifesciences USD 46.17B 3.3B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Globus Medical USD 11.69B 2M Mar/2026
Insulet USD 14.53B 5.46B Mar/2026
Integra LifeSciences USD 733M 234M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Masimo USD 9.35B 2.51B Mar/2026
Medtronic USD 94.38B 12.6B Jun/2026
Merit Medical Systems USD 4.11B 1.11B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Stryker USD 125.85B 8.57B Mar/2026
Teleflex USD 5.3B 99M Mar/2026
West Pharmaceutical Services USD 18.07B 1.73B Mar/2026
WK Kellogg Co USD 11.32B 2.42B Mar/2026
Zimmer Biomet Holdings USD 17.5B 321M Mar/2026